Aspira Women's Health Inc. (AWHL)
OTCMKTS · Delayed Price · Currency is USD
0.2750
-0.0450 (-14.06%)
Aug 20, 2026, 4:00 PM EDT
Aspira Women's Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8.55 | 9.22 | 9.18 | 9.15 | 8.18 | 6.81 | |
Revenue Growth | -8.00% | 0.37% | 0.31% | 11.85% | 20.14% | 46.46% |
Cost of Revenue | 3.52 | 3.3 | 3.7 | 3.89 | 3.86 | 3.75 |
Gross Profit | 5.02 | 5.92 | 5.48 | 5.26 | 4.32 | 3.06 |
Selling, General & Admin | 8.93 | 11.07 | 18.54 | 20.16 | 29.59 | 30.42 |
Research & Development | 3 | 2.76 | 3.21 | 3.96 | 5.87 | 5.24 |
Operating Expenses | 11.92 | 13.83 | 21.76 | 24.11 | 35.46 | 35.66 |
Operating Income | -6.9 | -7.91 | -16.28 | -18.85 | -31.14 | -32.6 |
Interest Expense | -0.47 | -0.04 | -0.03 | - | - | -0.05 |
Interest & Investment Income | - | - | - | 0.05 | 0.02 | - |
Other Non Operating Income (Expenses) | -2.6 | -4.8 | 3.22 | 0.52 | 1.24 | -0.03 |
EBT Excluding Unusual Items | -9.98 | -12.75 | -13.09 | -18.29 | -29.89 | -32.67 |
Other Unusual Items | -0.03 | -0.03 | - | 1.6 | - | 1.01 |
Pretax Income | -10.01 | -12.78 | -13.09 | -16.69 | -29.89 | -31.66 |
Net Income | -10.01 | -12.78 | -13.09 | -16.69 | -29.89 | -31.66 |
Net Income to Common | -10.01 | -12.78 | -13.09 | -16.69 | -29.89 | -31.66 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 42 | 34 | 14 | 9 | 8 | 7 |
Shares Outstanding (Diluted) | 42 | 34 | 14 | 9 | 8 | 7 |
Shares Change | 86.94% | 141.27% | 53.08% | 18.85% | 4.79% | 10.41% |
EPS (Basic) | -0.24 | -0.37 | -0.93 | -1.81 | -3.85 | -4.27 |
EPS (Diluted) | -0.24 | -0.37 | -0.93 | -1.81 | -3.85 | -4.27 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4.73 | -7.05 | -12.15 | -15.92 | -31.3 | -27.58 |
Free Cash Flow Per Share | -0.11 | -0.21 | -0.86 | -1.72 | -4.03 | -3.72 |
Gross Margin | 58.78% | 64.18% | 59.67% | 57.48% | 52.82% | 44.95% |
Operating Margin | -80.75% | -85.86% | -177.28% | -205.94% | -380.47% | -478.49% |
Profit Margin | -117.07% | -138.67% | -142.61% | -182.33% | -365.16% | -464.80% |
Free Cash Flow Margin | -55.32% | -76.44% | -132.32% | -173.89% | -382.45% | -404.86% |
EBITDA | -6.81 | -7.88 | -16.19 | -18.65 | -30.87 | -32.29 |
EBITDA Margin | -79.66% | -85.46% | -176.28% | -203.77% | - | - |
D&A For EBITDA | 0.09 | 0.04 | 0.09 | 0.2 | 0.26 | 0.3 |
EBIT | -6.9 | -7.91 | -16.28 | -18.85 | -31.14 | -32.6 |
EBIT Margin | -80.75% | -85.86% | -177.28% | -205.94% | - | - |
Revenue as Reported | 9.22 | 9.22 | 9.18 | 9.15 | 8.18 | 6.81 |